Trial site
Warszawski Szpital Okulistyczny Sp. z o.o.
Warsaw, 01-258, PolandEU-13 widening countryNot linked to an institution yet
- 11running trials
- 3closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Phase
- Phase 39 trials
- Phase 23 trials
- Phase 2/32 trials
- Status
- Active, not recruiting6 trials
- Recruiting4 trials
- Completed3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Boehringer Ingelheim2 trials
- Janssen Research & Development, LLC2 trials
- Amgen1 trial
- Annexon, Inc.1 trial
- Eyebiotech Limited1 trial
- and 7 more
Running trials
Recruiting
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
NCT07705555· Phase 3· Merck Sharp & Dohme LLC· Source
Recruiting
A randomized double-masked, multicenter, 3 arm pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 in participants with neovascular age-related macular degeneration (NVAMD)
2025-524575-22-00· Phase 2/3· Eyebiotech Limited· Source
Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
NCT07614776· Phase 3· Amgen· Source
Active, not recruiting
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
2025-523937-25-00· Phase 3· Eyepoint Inc.· Source
Recruiting
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
NCT06962839· Phase 2· Boehringer Ingelheim· Source
Active, not recruiting
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56
NCT06683742· Phase 3· EyePoint Pharmaceuticals, Inc.· Source
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
NCT06635148· Phase 2/3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)
NCT06510816· Phase 3· Annexon, Inc.· Source
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
NCT06321302· Phase 2· Boehringer Ingelheim· Source
Recruiting
Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).
NCT04663750· Phase 3· King's College Hospital NHS Trust· Source
Active, not recruiting
Study of OT-101 in Treating Myopia
NCT04770610· Phase 3· Ocumension (Hong Kong) Limited· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error